Cost-effectiveness of early detection of breast cancer in Catalonia (Spain)
Carles Lavila, Misericordia
Gregori Gomis, Aleix
Pla Farnós, Roger
Sala i Serra, Maria
MetadataShow full item record
Background: Breast cancer (BC) causes more deaths than any other cancer among women in Catalonia. Early detection has contributed to the observed decline in BC mortality. However, there is debate on the optimal screening strategy. We performed an economic evaluation of 20 screening strategies taking into account the cost over time of screening and subsequent medical costs, including diagnostic confirmation, initial treatment, follow-up and advanced care. Methods: We used a probabilistic model to estimate the effect and costs over time of each scenario. The effect was measured as years of life (YL), quality-adjusted life years (QALY), and lives extended (LE). Costs of screening and treatment were obtained from the Early Detection Program and hospital databases of the IMAS-Hospital del Mar in Barcelona. The incremental cost-effectiveness ratio (ICER) was used to compare the relative costs and outcomes of different scenarios. Results: Strategies that start at ages 40 or 45 and end at 69 predominate when the effect is measured as YL or QALYs. Biennial strategies 50-69, 45-69 or annual 45-69, 40-69 and 40-74 were selected as cost-effective for both effect measures (YL or QALYs). The ICER increases considerably when moving from biennial to annual scenarios. Moving from no screening to biennial 50-69 years represented an ICER of 4,469€ per QALY. Conclusions: A reduced number of screening strategies have been selected for consideration by researchers, decision makers and policy planners. Mathematical models are useful to assess the impact and costs of BC screening in a specific geographical area.
Is part ofBMC Cancer, 2011, vol. 11, núm. 192, p. 1-11
European research projects
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
Vilaprinyo Terré, Ester; Forné Izquierdo, Carles; Carles Lavila, Misericordia; Sala i Serra, Maria; Pla Farnós, Roger; Castells, Xavier; Domingo, Laia; Rué i Monné, Montserrat; Interval Cancer Study Group (Public Library of Science, 2014)The one-size-fits-all paradigm in organized screening of breast cancer is shifting towards a personalized approach. The present study has two objectives: 1) To perform an economic evaluation and to assess the harm-benefit ...
Rué i Monné, Montserrat; Vilaprinyo Terré, Ester; Lee, Sandra; Martínez Alonso, Montserrat; Carles Lavila, Misericordia; Marcos-Gragera, Rafael; Pla, Roger; Espinàs, Josep Alfons (BioMed Central, 2009)Background: At present, it is complicated to use screening trials to determine the optimal age intervals and periodicities of breast cancer early detection. Mathematical models are an alternative that has been widely used. ...
Evolución de la mortalidad por cáncer de mama y diseminación de la mamografía de cribado en Cataluña: un análisis por regiones sanitarias Pérez Lacasta, María José; Gregori Gomis, Aleix; Carles Lavila, Misericordia; Gispert i Magarolas, Rosa; Martínez Alonso, Montserrat; Vilaprinyo Terré, Ester; Pla Farnós, Roger; Rué i Monné, Montserrat (Espanya. Ministerio de Sanidad y Consumo, 2010)Fundamento: El descenso de las tasas de mortalidad por cáncer de mama (CM) se ha atribuido a la implantación de programas de cribado y a avances terapéuticos. El objetivo de este trabajo es comparar la evolución de su ...